Evaluating the adaptation of SMC implementation during COVID-19 in Karamoja, Uganda

The Sahel’s SMC implementation model is feasible in Uganda. We recommend scale-up in line with WHO guidelines.

Malaria reduction and elimination in Uganda require new interventions. In 2021, Malaria Consortium and the Ministry of Health conducted research on administering sulfadoxine-pyrimethamine and amodiaquine (SPAQ) over five cycles of seasonal malaria chemoprevention (SMC) in Moroto and Kotido districts, where malaria transmission is highly seasonal. Implementation took place during lockdown and at the peak of the COVID-19 pandemic. Our objective was to evaluate the adaptation of the Sahel’s SMC model and assess acceptability of its implementation among Uganda’s Karamojong pastoralist community.

This poster was presented at the 71st annual meeting of the American Society of Tropical Medicine and Hygiene.

Click here to download

Country: Uganda

Keywords: Community delivery | COVID-19 | Malaria | Research | SDGs | SMC